Colgate-Palmolive grants 205K options to CEO
Colgate-Palmolive’s CEO received new option and RSU awards on September 16, 2026, increasing both his direct and indirect equity holdings.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO (CL) reported that Chairman, President & CEO Noel R. Wallace received equity awards on September 16, 2026. He was granted 205,197 stock options to buy Common Stock at an exercise price of $87.02 per share, expiring September 16, 2036, under the company’s incentive compensation plan; these options become exercisable in equal annual installments over three years beginning on the first anniversary of the grant date. He also received 29,649 restricted stock units, which vest in equal one-third installments on each of the first, second and third anniversaries of the grant date. Following these awards, he holds 379,700 shares of Common Stock directly, plus indirect holdings of 54,868 shares through the issuer’s 401(k) plan trustee, 52,000 shares through a spouse trust, and 335 shares through another trust. No Rule 10b5-1 trading plan is reported for these grants.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 234,846 shares
Grant/Award
5 txns
Insider
Wallace Noel R.
Role
Chairman, President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2, F3 | 205,197 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 29,649 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 205,197 contracts (Direct);
Common Stock — 379,700 shares (Direct);
Common Stock — 54,868 shares (Indirect, By Issuer's 401(k) Plan Trustee);
Common Stock — 52,000 shares (Indirect, By Spouse Trust);
Common Stock — 335 shares (Indirect, By Trust)
Footnotes (3)
- F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
- F2. Stock option award granted under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 16, 2026 grant date.
Key Figures
Stock options granted: 205,197 options
Option exercise price: $87.02 per share
Option expiration date: September 16, 2036
+5 more
8 metrics
Stock options granted
205,197 options
Stock option award to CEO on September 16, 2026
Option exercise price
$87.02 per share
Exercise price for 205,197 stock options granted September 16, 2026
Option expiration date
September 16, 2036
Expiration for stock options granted to CEO
Restricted stock units granted
29,649 RSUs
Restricted stock unit award granted September 16, 2026
Direct common shares after transaction
379,700 shares
CEO’s direct Colgate-Palmolive Common Stock holdings following the award
401(k) plan indirect holdings
54,868 shares
Common Stock held indirectly by issuer’s 401(k) plan trustee
Spouse trust indirect holdings
52,000 shares
Common Stock held indirectly by spouse trust
Other trust indirect holdings
335 shares
Common Stock held indirectly by another trust
Key Terms
Restricted stock unit, Incentive compensation plan, Stock option, Grant date, +1 more
5 terms
Restricted stock unit financial
"Restricted stock unit award granted under the issuer's incentive compensation plan"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Incentive compensation plan financial
"Award granted under the issuer's incentive compensation plan"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
Stock option financial
"Stock option award granted under the issuer's incentive compensation plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Grant date financial
"First anniversary of the September 16, 2026 grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
401(k) Plan financial
"By Issuer's 401(k) Plan Trustee"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did CL grant to CEO Noel R. Wallace on September 16, 2026?
On September 16, 2026, Noel R. Wallace received 205,197 stock options with an exercise price of $87.02 per share expiring September 16, 2036, and 29,649 restricted stock units granted under Colgate-Palmolive’s incentive compensation plan.
How do the new restricted stock units for CL’s CEO vest?
The 29,649 restricted stock units granted to Colgate-Palmolive’s CEO vest in equal one-third installments on each of the first, second and third anniversaries of the September 16, 2026 grant date.
When do the new Colgate-Palmolive stock options for the CEO become exercisable?
The 205,197 stock options granted on September 16, 2026 become exercisable in equal annual installments over three years, beginning on the first anniversary of the September 16, 2026 grant date, and expire on September 16, 2036.
Were the CL CEO’s September 16, 2026 grants made under a Rule 10b5-1 plan?
No. The filing indicates that no Rule 10b5-1 trading plan is reported for the September 16, 2026 equity grants to Colgate-Palmolive’s CEO.
AI-generated analysis. How Rhea-AI works. Not financial advice.
